MLPA-NGS Hybrid Diagnostic Assay
The hybrid diagnostic assay combining multiplex ligation-dependent probe amplification (MLPA) with next-generation sequencing (NGS) is called digitalMLPA (also referred to as MLPA-based NGS or digital MLPA).
What is digitalMLPA?
DigitalMLPA is a novel molecular diagnostic technique that integrates the standard MLPA procedure with NGS technology to enable high-throughput screening of large numbers of genomic fragments and samples simultaneously 1, 2, 3. This hybrid approach overcomes the traditional limitation of conventional MLPA, which can only accommodate a maximum of 60 probes per test 1.
Technical Characteristics
The assay works by:
- Following the standard MLPA workflow (denaturation, hybridization of probes, ligation, and PCR amplification) 4
- Incorporating additional indices for detection that allow multiplexing 1
- Using NGS platforms (particularly Illumina) for readout instead of capillary electrophoresis 1, 2
- Enabling analysis of up to 1000 target sequences simultaneously 3, compared to the 50 probes maximum in conventional MLPA 4
Clinical Applications
DigitalMLPA has demonstrated robust performance in detecting:
- Copy number alterations (CNAs) including deletions, duplications, and amplifications 2, 3
- Large-scale chromosomal abnormalities such as whole chromosome gains/losses and hyperdiploidy 2, 3
- Intragenic deletions and fusion genes 3
- Point mutations (proof of principle shown with BRAF V600E detection) 2
- Subclonal alterations present in as little as 20-30% of neoplastic cells 3
Validated Disease Applications
The technique has been successfully validated in:
- Hematologic malignancies: Multiple myeloma 2, T- and B-cell acute lymphoblastic leukemia 3, and lymphomas 5
- Muscular dystrophies: Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA) 1, 6
- Myelodysplastic syndromes 7
Performance Metrics
In lymphoblastic leukemia, digitalMLPA demonstrated:
- Diagnostic sensitivity: 98.9%
- Specificity: 97.8%
- Congruency with conventional methods (iFISH, MLPA): 95% 2, 3
Advantages Over Conventional MLPA
- Dramatically increased probe capacity (up to 1000 vs. 60 targets) 1, 3
- Detailed mapping of complex CNAs, particularly useful for chromosome 1 abnormalities where 24 different patterns were identified in a single study 2
- Detection of aberrations missed by conventional methods - in multiple myeloma, digitalMLPA revealed 156 CNAs not detected by iFISH or conventional MLPA in 80% of patients 2
- Precise characterization of hyperdiploid karyotypes not efficiently achievable by other methods 2
- Cost-effectiveness compared to comprehensive NGS panels while maintaining high throughput 4, 1
Important Caveats
The sensitivity for detecting heterozygous deletions requires ≥20% tumor cell content, and ≥40% for duplication detection 4. This is a critical limitation when analyzing samples with low tumor burden or high normal cell contamination.